Design, synthesis, and neurochemical evaluation of 5-(3-alkyl-1,2,4- oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidines as M1 muscarinic receptor agonists.

MLA

Dunbar, P. G., et al. “Design, Synthesis, and Neurochemical Evaluation of 5-(3-Alkyl-1,2,4- Oxadiazol-5-Yl)-1,4,5,6-Tetrahydropyrimidines as M1 Muscarinic Receptor Agonists.” Journal of Medicinal Chemistry, vol. 36, no. 7, Apr. 1993, pp. 842–47. EBSCOhost, https://doi.org/10.1021/jm00059a008.

APA

Dunbar, P. G., Durant, G. J., Fang, Z., Abuh, Y. F., el-Assadi, A. A., Ngur, D. O., Periyasamy, S., Hoss, W. P., & Messer, W. S., Jr. (1993). Design, synthesis, and neurochemical evaluation of 5-(3-alkyl-1,2,4- oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidines as M1 muscarinic receptor agonists. Journal of Medicinal Chemistry, 36(7), 842–847. https://doi.org/10.1021/jm00059a008

Chicago

Dunbar, P G, G J Durant, Z Fang, Y F Abuh, A A el-Assadi, D O Ngur, S Periyasamy, W P Hoss, and W S Messer Jr. 1993. “Design, Synthesis, and Neurochemical Evaluation of 5-(3-Alkyl-1,2,4- Oxadiazol-5-Yl)-1,4,5,6-Tetrahydropyrimidines as M1 Muscarinic Receptor Agonists.” Journal of Medicinal Chemistry 36 (7): 842–47. doi:10.1021/jm00059a008.